Osteoporosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Circ-VANGL1 promotes the development of OP via binding to miRNA-217 to downregulate RUNX2 expression.
|
30779060 |
2019 |
Progression of non-small cell lung cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2.
|
31076544 |
2019 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of the core PCP pathway component VANGL1 suppresses the motility of GBM cell lines, pointing to an important mechanistic role for this pathway in glioblastoma malignancy.
|
28481871 |
2017 |
Androgen-Insensitivity Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We analyzed the coding region of the VANGL1 gene for mutations using Sanger sequencing in 157 unrelated patients with moderate to severe AIS.
|
27755493 |
2017 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of the core PCP pathway component VANGL1 suppresses the motility of GBM cell lines, pointing to an important mechanistic role for this pathway in glioblastoma malignancy.
|
28481871 |
2017 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of the core PCP pathway component VANGL1 suppresses the motility of GBM cell lines, pointing to an important mechanistic role for this pathway in glioblastoma malignancy.
|
28481871 |
2017 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of the core PCP pathway component VANGL1 suppresses the motility of GBM cell lines, pointing to an important mechanistic role for this pathway in glioblastoma malignancy.
|
28481871 |
2017 |
Congenital Abnormality
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The single nucleotide polymorphism (SNP) of the vangl1 gene is highly correlated with Neural Tube Defects (NTDs), a group of severe congenital malformations.
|
26914375 |
2016 |
Adenocarcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
When we crossed villin-KITENIN mice with APC(min/+) mice, intestinal tumor tissues in the crossed mice showed the characteristics of early-stage invading adenocarcinoma.
|
26527747 |
2016 |
Adenomatous Polyposis Coli
|
0.010 |
Biomarker
|
disease |
BEFREE |
When we crossed villin-KITENIN mice with APC(min/+) mice, intestinal tumor tissues in the crossed mice showed the characteristics of early-stage invading adenocarcinoma.
|
26527747 |
2016 |
Atrial Premature Complexes
|
0.010 |
Biomarker
|
disease |
BEFREE |
Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
|
26527747 |
2016 |
Intestinal adenoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here we tested whether elevated KITENIN and ErbB4 contribute to further progression of intestinal adenoma following APC loss.
|
26527747 |
2016 |
Colon adenoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
|
26527747 |
2016 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Thus, our findings identify that KITENIN-targeting miR-124, miR-27a, and miR-30b function as endogenous inhibitors of CRC cell motility and demonstrate that miR-124 among KITENIN-targeting microRNAs plays a suppressor role in colorectal tumorigenesis.
|
24909917 |
2014 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.
|
22179838 |
2012 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.
|
22179838 |
2012 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In syngeneic mouse squamous tumor models, more increased tumor volume and enhanced lung metastasis were found in SCC VII/KITENIN cells-injected mice.
|
19166844 |
2009 |
Spina Bifida
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We identified five novel missense variants in VANGL1, p.Ser83Leu, p.Phe153Ser, p.Arg181Gln, p.Leu202Phe and p.Ala404Ser, occurring in sporadic and familial cases of spinal dysraphisms.
|
19319979 |
2009 |
Secondary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
In syngeneic mouse squamous tumor models, more increased tumor volume and enhanced lung metastasis were found in SCC VII/KITENIN cells-injected mice.
|
19166844 |
2009 |
Colonic Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
|
16204073 |
2005 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
STB2 is highly expressed in MKN28, MKN74 (gastric cancer), BxPC-3, PSN-1, and Hs766T (pancreatic cancer) cells.
|
12060845 |
2002 |
Pancreatic carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
STB2 is highly expressed in MKN28, MKN74 (gastric cancer), BxPC-3, PSN-1, and Hs766T (pancreatic cancer) cells.
|
12060845 |
2002 |
Malignant neoplasm of pancreas
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
STB2 is highly expressed in MKN28, MKN74 (gastric cancer), BxPC-3, PSN-1, and Hs766T (pancreatic cancer) cells.
|
12060845 |
2002 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
STB2 is highly expressed in MKN28, MKN74 (gastric cancer), BxPC-3, PSN-1, and Hs766T (pancreatic cancer) cells.
|
12060845 |
2002 |
Malignant neoplasm of urinary bladder
|
0.020 |
Biomarker
|
disease |
BEFREE |
Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
|
31758655 |
2020 |